Literature DB >> 29120755

Migrating into the Tumor: a Roadmap for T Cells.

Lieke L van der Woude1, Mark A J Gorris2, Altuna Halilovic3, Carl G Figdor4, I Jolanda M de Vries5.   

Abstract

Tumors can be divided into 'hot' (T cell inflamed) or 'cold' (T cell noninflamed) according to the presence of immune cells. In this review, we discuss variables that influence T cell migration into the tumor microenvironment. Chemokines can attract T cells to the tumor site and tumor intrinsic pathways can influence the composition of local chemokines. Tumor-induced vasculature can hamper T cell migration. Other immune cells and tumor-derived molecules can block T cell proliferation and survival. It is important to better understand these mechanisms in order to target them therapeutically. Enhancing T cell infiltration may increase response rates to immunotherapy and increase survival.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cells; biomarkers; immune cells; immunotherapy; migration; tumor microenvironment.

Mesh:

Year:  2017        PMID: 29120755     DOI: 10.1016/j.trecan.2017.09.006

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  86 in total

1.  Lipid Metabolism in Tumor-Infiltrating T Cells.

Authors:  Shangwen He; Ting Cai; Juanjuan Yuan; Xiaojun Zheng; Wei Yang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.

Authors:  Simon Pernot; Magali Terme; Nina Radosevic-Robin; Florence Castan; Cécile Badoual; Elie Marcheteau; Fréderique Penault-Llorca; Olivier Bouche; Jaafar Bennouna; Eric Francois; Francois Ghiringhelli; Christelle De La Fouchardiere; Emmanuelle Samalin; Jean Baptiste Bachet; Christophe Borg; Valérie Boige; Thibault Voron; Trevor Stanbury; Eric Tartour; Sophie Gourgou; David Malka; Julien Taieb
Journal:  Gastric Cancer       Date:  2019-07-02       Impact factor: 7.370

3.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.

Authors:  Isabel Theresa Schobert; Lynn Jeanette Savic; Julius Chapiro; Khaled Bousabarah; Evan Chen; Fabian Laage-Gaupp; Jonathan Tefera; Nariman Nezami; MingDe Lin; Jeffrey Pollak; Todd Schlachter
Journal:  Eur Radiol       Date:  2020-05-19       Impact factor: 5.315

4.  Cytotoxic T cells swarm by homotypic chemokine signalling.

Authors:  Jorge Luis Galeano Niño; Sophie V Pageon; Szun S Tay; Feyza Colakoglu; Daryan Kempe; Jack Hywood; Jessica K Mazalo; James Cremasco; Matt A Govendir; Laura F Dagley; Kenneth Hsu; Simone Rizzetto; Jerzy Zieba; Gregory Rice; Victoria Prior; Geraldine M O'Neill; Richard J Williams; David R Nisbet; Belinda Kramer; Andrew I Webb; Fabio Luciani; Mark N Read; Maté Biro
Journal:  Elife       Date:  2020-10-13       Impact factor: 8.140

5.  Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?

Authors:  Lynn Jeanette Savic; Luzie A Doemel; Isabel Theresa Schobert; Ruth Rebecca Montgomery; Nikhil Joshi; John James Walsh; Jessica Santana; Vasily Pekurovsky; Xuchen Zhang; MingDe Lin; Lucas Adam; Annemarie Boustani; James Duncan; Lin Leng; Richard John Bucala; S Nahum Goldberg; Fahmeed Hyder; Daniel Coman; Julius Chapiro
Journal:  Radiology       Date:  2020-07-07       Impact factor: 11.105

Review 6.  Genomic profile and immune contexture in colorectal cancer-relevance for prognosis and immunotherapy.

Authors:  Sandra Meršaková; Zora Lasabová; Ján Strnádel; Michal Kalman; Eva Gabonova; Peter Sabaka; Rachele Ciccocioppo; Luis Rodrigo; Peter Kruzliak; Peter Mikolajčík
Journal:  Clin Exp Med       Date:  2020-07-27       Impact factor: 3.984

7.  JMJD3 regulates CD4 T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4.

Authors:  Chuntang Fu; Qingtian Li; Jia Zou; Changsheng Xing; Mei Luo; Bingnan Yin; Junjun Chu; Jiaming Yu; Xin Liu; Helen Y Wang; Rong-Fu Wang
Journal:  J Clin Invest       Date:  2019-08-08       Impact factor: 14.808

8.  Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model.

Authors:  Francesco Alessandrini; Laura Menotti; Elisa Avitabile; Irene Appolloni; Davide Ceresa; Daniela Marubbi; Gabriella Campadelli-Fiume; Paolo Malatesta
Journal:  Oncogene       Date:  2019-02-12       Impact factor: 9.867

Review 9.  Functional genomics: paving the way for more successful cancer immunotherapy.

Authors:  Reham Ajina; Danielle Zamalin; Louis M Weiner
Journal:  Brief Funct Genomics       Date:  2019-03-22       Impact factor: 4.241

10.  Selective reactivation of STING signaling to target Merkel cell carcinoma.

Authors:  Wei Liu; Gloria B Kim; Nathan A Krump; Yuqi Zhou; James L Riley; Jianxin You
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.